.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Risk-Sharing in the Pharmaceutical Industry
Gerrit Reepmeyer
€ 131.15
FREE Delivery in Ireland
Description for Risk-Sharing in the Pharmaceutical Industry
Paperback. Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of Adverse Selection to analyze the topic theoretically. Series: Contributions to Management Science. Num Pages: 297 pages, 70 black & white illustrations, 10 black & white tables, biography. BIC Classification: KNDP. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 16. Weight in Grams: 970.
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ ... Read more
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ ... Read more
Product Details
Format
Paperback
Publication date
2005
Publisher
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Germany
Number of pages
297
Condition
New
Series
Contributions to Management Science
Number of Pages
297
Place of Publication
Heidelberg, Germany
ISBN
9783790816679
SKU
V9783790816679
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Risk-Sharing in the Pharmaceutical Industry